Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

(MM) (IDIX)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IDIX
DateTimeSourceHeadlineSymbolCompany
06/06/201421:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
06/06/201421:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
06/06/201421:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
06/06/201421:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
05/05/201411:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDIX(MM)
01/05/201421:05GlobeNewswire Inc.Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline ReviewNASDAQ:IDIX(MM)
30/04/201413:00GlobeNewswire Inc.Idenix Pharmaceuticals to Present at Three Upcoming Healthcare ConferencesNASDAQ:IDIX(MM)
08/04/201418:15PR Newswire (US)Morning Review on Top Gainers -- Research on Peregrine Pharma, Agios Pharma, Idenix Pharma, and Lexicon PharmaNASDAQ:IDIX(MM)
07/04/201413:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDIX(MM)
07/04/201412:00GlobeNewswire Inc.Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment ...NASDAQ:IDIX(MM)
03/04/201413:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDIX(MM)
03/04/201413:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDIX(MM)
24/03/201412:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDIX(MM)
24/03/201412:00GlobeNewswire Inc.Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of...NASDAQ:IDIX(MM)
24/03/201411:00GlobeNewswire Inc.Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity CaseNASDAQ:IDIX(MM)
21/03/201412:00PR Newswire (US)Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros,...NASDAQ:IDIX(MM)
19/03/201412:15PR Newswire (US)Top Gainers under Review -- Research on Coeur Mining, Eagle Rock Energy Partners, Idenix Pharma, and WidePointNASDAQ:IDIX(MM)
14/03/201412:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDIX(MM)
14/03/201411:00GlobeNewswireIdenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in EuropeNASDAQ:IDIX(MM)
14/03/201411:00GlobeNewswire Inc.Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in EuropeNASDAQ:IDIX(MM)
11/03/201417:22Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IDIX(MM)
27/02/201421:05GlobeNewswire Inc.Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial ResultsNASDAQ:IDIX(MM)
26/02/201413:00GlobeNewswire Inc.Idenix Pharmaceuticals to Present at Two Upcoming Healthcare ConferencesNASDAQ:IDIX(MM)
14/02/201422:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDIX(MM)
14/02/201421:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDIX(MM)
12/02/201422:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
12/02/201422:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDIX(MM)
12/02/201421:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
12/02/201421:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
12/02/201421:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDIX(MM)
 Showing the most relevant articles for your search:NASDAQ:IDIX